Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell

Figure 2

Survival analysis of RAC2 in pancancer. Prognostic analysis of RAC2 by multivariate Cox regression: (a) the observation of the overall survival of 33 tumors by RAC2; (b) the observation of disease-specific survival in 33 tumors by RAC2; (c) results of RAC2 on pancancer progression interval; (d) cancers with a significant prognostic association with RAC2 in pancancer overall survival; (e) cancer where RAC2 is significantly associated with prognosis in pancancer disease-specific survival; (f) cancers with a significant prognostic association with RAC2 in the pancancer progression-free interval period.

(a)

(b)

(c)

(d)

(e)

(f)